Replies to post #964 on Biotech Values

[DewDiligence]

Re: Chloride-channel patent:

>> Levitt has been predicting obtaining IP on this in '04 and licensing it to big pharma; apparently a number of companies are already investigating this target. <<

Good find. Levitt has indeed mentioned a pending patent (or patents) in this area in all of his recent presentations and interviews.

Here’s something that caught my eye but probably signifies nothing of consequence:

"…therapeutic application of compounds in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases."

The use of the term “COPD” in the patent language refers to a superset of asthma, but COPD is more commonly used to denote a specific respiratory disease that is considered distinct from asthma.

[BullNBear52]

Did you notice the date? Guess they had nothing better to do that day. lol.

MUCIN SYNTHESIS INHIBITORS Patent Application Pub Dec 25, 2003.
20030236220

I had to check.

http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fn...